Final approval from USFDA granted for the ANDA Timolol
Maleate Ophthalmic Solution USP, 0.5% (Eye drops), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) TIMOPTIC, from Bausch and Lomb Inc, to our Subsidiary Caplin Steriles Limited.
Timolol Maleate Ophthalmic Solution USP, 0.5% (Eye drops) is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma. According to IQVIATM (IMS Health), Timolol Maleate Ophthalmic Solution USP, 0.5% had US sales of approximately $45 million for the 12-month period ending June 2024.
Not sure what % of market Caplin is eyeing.
| Subscribe To Our Free Newsletter |
